This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Vogler, M. Articles by Fulda, S. Search for Related Content PubMed PubMed Citation Articles by Vogler, M. Articles by Fulda, S.

Targeting XIAP Bypasses Bcl-2–Mediated Resistance to TRAIL and Cooperates with TRAIL to Suppress Pancreatic Cancer Growth In vitro and In vivo

¹ Divison of Apoptosis Regulation, German Cancer Research Center, Heidelberg, Germany; ² University Children's Hospital and ³ Department of Urology, Ulm University, and ⁴ Institute of Pharmacology of Natural Products and Clinical Pharmacology, Ulm, Germany

Requests for reprints: Simone Fulda, University Children's Hospital, Eythstr. 24, D-89075 Ulm, Germany. Phone: 49-731-5005-7034; Fax: 49-731-5005-7042; E-mail: simone.fulda{at}uniklinik-ulm.de.

Key Words: XIAP • apoptosis • TRAIL • pancreatic cancer

Resistance to apoptosis is a hallmark of pancreatic cancer, a leading cause of cancer deaths. Therefore, novel strategies are required to target apoptosis resistance. Here, we report that the combination of X-linked inhibitor of apoptosis (XIAP) inhibition and tumor necrosis factor–related apoptosis-inducing ligand (TRAIL) is an effective approach to trigger apoptosis despite Bcl-2 overexpression and to suppress pancreatic cancer growth in vitro and in vivo. Knockdown of XIAP by RNA interference cooperates with TRAIL to induce caspase activation, loss of mitochondrial membrane potential, cytochrome c release, and apoptosis in pancreatic carcinoma cells. Loss of mitochondrial membrane potential and cytochrome c release are extensively inhibited by a broad range or caspase-3 selective caspase inhibitor and by RNAi-mediated silencing of caspase-3, indicating that XIAP inhibition enhances TRAIL-induced mitochondrial damage in a caspase-3–dependent manner. XIAP inhibition combined with TRAIL even breaks Bcl-2–imposed resistance by converting type II cells that depend on the mitochondrial contribution to the death receptor pathway to type I cells in which TRAIL-induced activation of caspase-3 and caspase-9 and apoptosis proceeds irrespective of high Bcl-2 levels. Most importantly, XIAP inhibition potentiates TRAIL-induced antitumor activity in two preclinical models of pancreatic cancer in vivo. In the chicken chorioallantoic membrane model, XIAP inhibition significantly enhances TRAIL-mediated apoptosis and suppression of tumor growth. In a tumor regression model in xenograft-bearing mice, XIAP inhibition acts in concert with TRAIL to cause even regression of established pancreatic carcinoma. Thus, this combination of XIAP inhibition plus TRAIL is a promising strategy to overcome apoptosis resistance of pancreatic cancer that warrants further investigation. [Cancer Res 2008;68(19):7956–65]

This article has been cited by other articles:

				P. Geserick, M. Hupe, M. Moulin, W. W.-L. Wong, M. Feoktistova, B. Kellert, H. Gollnick, J. Silke, and M. Leverkus Cellular IAPs inhibit a cryptic CD95-induced cell death by limiting RIP1 kinase recruitment J. Cell Biol., December 28, 2009; 187(7): 1037 - 1054. [Abstract] [Full Text] [PDF]

				S. Loeder, T. Zenz, A. Schnaiter, D. Mertens, D. Winkler, H. Dohner, K.-M. Debatin, S. Stilgenbauer, and S. Fulda A Novel Paradigm to Trigger Apoptosis in Chronic Lymphocytic Leukemia Cancer Res., December 1, 2009; 69(23): 8977 - 8986. [Abstract] [Full Text] [PDF]

				Z. Zhang, Y. Huang, K. Newman, J. Gu, X. Zhang, H. Wu, M. Zhao, Z. Xianyu, and X. Liu Reexpression of Human Somatostatin Receptor Gene 2 Gene Mediated by Oncolytic Adenovirus Increases Antitumor Activity of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand against Pancreatic Cancer Clin. Cancer Res., August 15, 2009; 15(16): 5154 - 5160. [Abstract] [Full Text] [PDF]